Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Current Opinion in Obstetrics & Gynecology|December 30, 2021
Triple negative breast cancer: any closer to cracking the code?Parvin F PeddiCurrent Opinion in Obstetrics & Gynecology|December 19, 2017
Hormone receptor positive breast cancer: state of the artParvin F PeddiTherapeutic Advances in Medical Oncology|October 25, 2014
Ado-trastuzumab emtansine (T-DM1) in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer: latest evidence and clinical potentialParvin F Peddi, Sara A HurvitzFuture Oncology (London, England)|March 9, 2013
Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancerParvin F Peddi, Sara A HurvitzCurrent Opinion in Obstetrics & Gynecology|December 28, 2020
Frontiers in HER2-positive breast cancer in 2020Parvin F Peddi, Dennis J SlamonJournal of the National Comprehensive Cancer Network : JNCCN|November 10, 2012
Successful resection after neoadjuvant therapy in pancreatic adenocarcinomaParvin F Peddi, Andrea Wang-GillamJournal of Neuro-Oncology|January 29, 2014
PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancerParvin F Peddi, Sara A HurvitzInternational Journal of Breast Cancer|February 2, 2012
Molecular basis of triple negative breast cancer and implications for therapyParvin F Peddi, Matthew J Ellis, Cynthia MaThe Surgical Clinics of North America|August 21, 2016
Management of Breast SarcomaCary Hsu, Susan A McCloskey, Parvin F PeddiCancer Treatment Reviews|September 10, 2013
Noninfectious pneumonitis with the use of mTOR inhibitors in breast cancerParvin F Peddi, Rebecca A Shatsky, Sara A HurvitzPageof 2